As you form your opinion of the deal, it isn't difficult to guess how those who bought in the .40's feel. Such a great product, it's a shame Jed Kennedy and his management team could not successfully market it. Looking back at the presentation that has been on their website for over a year with it's 5% market share projected to be $100,000,000 in sales, my opinion is that Conmed is getting a great deal and current shareholders lost out on a great opportunity compliments of incompetent executives.
They sold 10 systems in 3 months? And none in the U.S.? Am I reading that correctly? I'm probably too skeptical, but it sure looks like they weren't even trying.
